These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19383822)

  • 1. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
    Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
    Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
    Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
    J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
    Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
    Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.
    Comerford I; Milasta S; Morrow V; Milligan G; Nibbs R
    Eur J Immunol; 2006 Jul; 36(7):1904-16. PubMed ID: 16791897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous expression of the atypical chemokine receptor CCX-CKR (CCRL1) gene in human embryonic kidney (HEK 293) cells.
    Salimi P; Esmaeili A; Hashemi M; Behjati M
    Mol Cell Biochem; 2016 Jan; 412(1-2):229-33. PubMed ID: 26699909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The atypical chemokine receptor CCX-CKR scavenges homeostatic chemokines in circulation and tissues and suppresses Th17 responses.
    Comerford I; Nibbs RJ; Litchfield W; Bunting M; Harata-Lee Y; Haylock-Jacobs S; Forrow S; Korner H; McColl SR
    Blood; 2010 Nov; 116(20):4130-40. PubMed ID: 20562329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a panel of monoclonal antibodies against atypical chemokine receptor CCX-CKR by DNA immunization.
    Takatsuka S; Sekiguchi A; Tokunaga M; Fujimoto A; Chiba J
    J Pharmacol Toxicol Methods; 2011; 63(3):250-7. PubMed ID: 21184834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CCX CKR in pulmonary sarcoidosis.
    Kriegova E; Tsyrulnyk A; Arakelyan A; Mrazek F; Ordeltova M; Petzmann S; Zatloukal J; Kolek V; du Bois RM; Popper H; Petrek M
    Inflamm Res; 2006 Oct; 55(10):441-5. PubMed ID: 17109071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCX-CKR expression in colorectal cancer and patient survival.
    Zhu Y; Tang W; Liu Y; Wang G; Liang Z; Cui L
    Int J Biol Markers; 2014 Mar; 29(1):e40-8. PubMed ID: 24338720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of mouse CCX-CKR, a receptor for the lymphocyte-attracting chemokines TECK/mCCL25, SLC/mCCL21 and MIP-3beta/mCCL19: comparison to human CCX-CKR.
    Townson JR; Nibbs RJ
    Eur J Immunol; 2002 May; 32(5):1230-41. PubMed ID: 11981810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient expression of recombinant ACKR4 (CCRL1) gene, an atypical chemokine receptor in human embryonic kidney (HEK 293) cells.
    Parsi B; Esmaeili A; Hashemi M; Behjati M
    Mol Biol Rep; 2016 Jul; 43(7):583-9. PubMed ID: 27168154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
    Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
    Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
    Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
    Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCX-CKR deficiency alters thymic stroma impairing thymocyte development and promoting autoimmunity.
    Bunting MD; Comerford I; Seach N; Hammett MV; Asquith DL; Körner H; Boyd RL; Nibbs RJ; McColl SR
    Blood; 2013 Jan; 121(1):118-28. PubMed ID: 23152546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CXCR3-mediated chemotaxis by the human chemokine receptor-like protein CCX-CKR.
    Vinet J; van Zwam M; Dijkstra IM; Brouwer N; van Weering HR; Watts A; Meijer M; Fokkens MR; Kannan V; Verzijl D; Vischer HF; Smit MJ; Leurs R; Biber K; Boddeke HW
    Br J Pharmacol; 2013 Mar; 168(6):1375-87. PubMed ID: 23121557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
    Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
    Med Oncol; 2014 Sep; 31(9):145. PubMed ID: 25097078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of breast cancer metastasis by atypical chemokine receptors.
    Cheng X; Hung MC
    Clin Cancer Res; 2009 May; 15(9):2951-3. PubMed ID: 19383808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRAM-A indicates IFN-γ-associated inflammatory response in breast cancer.
    Sarmadi P; Tunali G; Esendagli-Yilmaz G; Yilmaz KB; Esendagli G
    Mol Immunol; 2015 Dec; 68(2 Pt C):692-8. PubMed ID: 26563945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.
    Wang J; Ou ZL; Hou YF; Luo JM; Shen ZZ; Ding J; Shao ZM
    Oncogene; 2006 Nov; 25(54):7201-11. PubMed ID: 16785997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCL25-CCR9 interaction modulates ovarian cancer cell migration, metalloproteinase expression, and invasion.
    Johnson EL; Singh R; Singh S; Johnson-Holiday CM; Grizzle WE; Partridge EE; Lillard JW
    World J Surg Oncol; 2010 Jul; 8():62. PubMed ID: 20649989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.